No results for ‘’
Hindustan Bio Sciences Ltd
NSE: BSE: 532041
₹8.70
(1.75%)
Sat, 30 May 2026, 05:28 pm
Market Cap87.64M
PE Ratio61.35
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KCompany History
2001
- The Company entered into an agreement with CDSL, NSDL and Venture Capital & Corporate Investments Ltd for dematerialisation.
2004
- Hindustan Bio bagged GEAC nod for recombinant human erythropoietin.
2005
- Hindustan Bio Sciences Ltd received an order for Antiretroviral drug for a value of Rs 269.30 million from China.